AlenMed Promotion SIA is an international team of experts in the field of marketing and distribution of medical products. The company was established in 2005 based on longstanding experience of successful cooperation with multinational pharmaceutical companies.
Since its foundation, AlenMed Promotion SIA has been focusing on innovations, professionalism, and custom-tailored approach. This focus helps easily respond to the challenges of traditionally developing spheres as well as cutting-edge high-tech achievements of modern pharmaceutics.
After a short period of time the company has been granted the distributor status with several Swiss pharmaceutical manufacturers, winning absolute trust of international partners. Presently, AlenMed holds an EU License for trading in pharmaceutical products and has a partner network in Eastern Europe and Central Asia.
A credit of trust to the company has been granted a long time ago, and AlenMed Promotion SIA, in its turn, is open for cooperation. Currently, AlenMed is closely cooperating with such renowned international pharmaceutical companies as Merck Serono (Switzerland), Axellus (Norway), Cook Medical (Ireland), Hospira (UK), and Certmedica (Germany).
AlenMed aims at long-term and trust relationship with partners. A concept of “high partnership level” and focus upon “intangible investment” into the staff and local partners have built great prestige and developed company’s well-earned reputation in the international scientific community and among pharmaceutical manufacture companies. This has contributed to AlenMed’s image of a qualified and reliable partner operating on the forefront of contemporary medical tendencies and current market demands.
Well-structured logistical, distributional, representative and expert-partnership networks, combined with strong marketing and registration support, make it possible for AlenMed Promotion SIA to offer flexibility of supplies, prompt registration and product promotion services. This approach creates an “integrated support cycle” service unique to the pharmaceutical market, being a powerful alternative to the manufacturers’ traditional market entrance strategy — opening regional representative offices.